A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS

Clinical trial NCT02732184 · COMPLETED

Trial details

NCT number: NCT02732184
Sponsor: Immedica Pharma AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2016-08-15
Primary completion: 2017-11-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.